CV, a Phase 2 dose-ranging proof-of-concept trial of BGE-102 measuring inflammatory and cardiometabolic biomarkers; topline data anticipated in the second half of 2026 QUELL-DME, Phase 1b/2a ...

EDIT-401 on track for CTN submission this month with data update in Q1 2027Recently presented pre-clinical data demonstrating ~90% or greater ...

Liverpool have only signed one player so far this summer. The Reds' fanbase were led to believe that another rebuild was on ...

ST. JOHN'S — British oil company BP says it withdrew from the proposed Bay du Nord offshore oil project off the east coast of ...

Dominion Energy must return to Virginia regulators this fall with proposed changes that could shift more transmission ...

Leadership can mean leveraging one success to create the next — and navigating hundreds of crucial steps in between. It can ...

August 4, 2026) - Rua Gold Inc. (TSX: RUA) (NZX: RGI) (OTCQX: NZAUF) (FSE: X9R) ("RUA GOLD" or the "Company") is pleased to announce that it has received required regulatory approval to commence ...

Amazon is just one of many retailers who have received large tariff refunds. The retail giant says it plans to issue refunds ...

Leadership can mean leveraging one success to create the next — and navigating hundreds of crucial steps in between. It can ...

The Prime Minister's drive for devolution could accelerate languishing infrastructure projects ...

Originally a fishing outpost, St. John’s may seem like an unlikely place for a tech boom. In focus today are the factors that have helped Newfoundland stem the brain drain – and what the rest of ...

Ocular’s AXPAXLI TM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting with the U.S. FDA in May 2026. FDA Type C Meeting Minutes Formalize SOL-1 Trial ...